[1] KOICHI FUJIMOTO. Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.[J]. Antimicrobial Agents and Chemotherapy, 2013, 57 2: 697-707. DOI:
10.1128/aac.01051-12[2] SAUGATA HAZRA John S B Hua Xu. Tebipenem, a New Carbapenem Antibiotic, Is a Slow Substrate That Inhibits the β-Lactamase from Mycobacterium tuberculosis[J]. Biochemistry Biochemistry, 2014, 53 22: 3671-3678. DOI:
10.1021/bi500339j